Jennifer Fox

Jennifer Fox

Chief Business Officer and Chief Financial OfficeratZenas BioPharma· In proxies 2023–2024

Pay in FY2024+88% from the year before

Jennifer Fox was paid $4.8M in FY2024 (Dec), up 88%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Zenas BioPharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Zenas BioPharmaPublic company · 3 yr
    • Chief Business Officer and Chief Financial Officer2023 – Present · 3 yrStock in role +59%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?